USA patient infection HIV USA

FDA approves first monthly injectable HIV treatment

Reading now: 285
mambaonline.com

In a major development in the treatment of HIV, a once-a-month injection to replace the current daily pill regime has been approved by the US Food and Drug Administration (FDA). The agency approved Cabenuva (an injectable combination of the drugs cabotegravir and rilpivirin) as a complete treatment of HIV type 1 (the most common type of HIV) infection in adults.

The approval applies to HIV positive individuals who are virologically suppressed on a stable antiretroviral (ARV) regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.

This is the first FDA-approved injectable, complete regimen for HIV-infected adults that is administered once a month. “Currently, the standard

Read more on mambaonline.com
The website starsalert.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA